nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—bone cancer	0.8	1	CbGaD
Tiagabine—Liver function test abnormal—Doxorubicin—bone cancer	0.000262	0.00131	CcSEcCtD
Tiagabine—Dyspnoea—Cisplatin—bone cancer	0.000262	0.00131	CcSEcCtD
Tiagabine—Erectile dysfunction—Methotrexate—bone cancer	0.000261	0.0013	CcSEcCtD
Tiagabine—Dry skin—Doxorubicin—bone cancer	0.00026	0.0013	CcSEcCtD
Tiagabine—Orthostatic hypotension—Doxorubicin—bone cancer	0.00026	0.00129	CcSEcCtD
Tiagabine—Photosensitivity reaction—Methotrexate—bone cancer	0.000259	0.00129	CcSEcCtD
Tiagabine—Hypokalaemia—Doxorubicin—bone cancer	0.000259	0.00129	CcSEcCtD
Tiagabine—Angina pectoris—Epirubicin—bone cancer	0.000259	0.00129	CcSEcCtD
Tiagabine—Decreased appetite—Cisplatin—bone cancer	0.000256	0.00127	CcSEcCtD
Tiagabine—Bronchitis—Epirubicin—bone cancer	0.000255	0.00127	CcSEcCtD
Tiagabine—Pneumonia—Methotrexate—bone cancer	0.000254	0.00127	CcSEcCtD
Tiagabine—Depression—Methotrexate—bone cancer	0.000252	0.00126	CcSEcCtD
Tiagabine—Gastritis—Doxorubicin—bone cancer	0.000252	0.00125	CcSEcCtD
Tiagabine—Pain—Cisplatin—bone cancer	0.000251	0.00125	CcSEcCtD
Tiagabine—Muscular weakness—Doxorubicin—bone cancer	0.000251	0.00125	CcSEcCtD
Tiagabine—Renal failure—Methotrexate—bone cancer	0.000249	0.00124	CcSEcCtD
Tiagabine—Dysuria—Epirubicin—bone cancer	0.000248	0.00124	CcSEcCtD
Tiagabine—Stomatitis—Methotrexate—bone cancer	0.000247	0.00123	CcSEcCtD
Tiagabine—Conjunctivitis—Methotrexate—bone cancer	0.000246	0.00123	CcSEcCtD
Tiagabine—Asthma—Doxorubicin—bone cancer	0.000246	0.00123	CcSEcCtD
Tiagabine—Influenza—Doxorubicin—bone cancer	0.000246	0.00123	CcSEcCtD
Tiagabine—Dysphagia—Doxorubicin—bone cancer	0.000246	0.00123	CcSEcCtD
Tiagabine—Pollakiuria—Epirubicin—bone cancer	0.000245	0.00122	CcSEcCtD
Tiagabine—Sweating—Methotrexate—bone cancer	0.000242	0.00121	CcSEcCtD
Tiagabine—Photosensitivity reaction—Epirubicin—bone cancer	0.000242	0.00121	CcSEcCtD
Tiagabine—Feeling abnormal—Cisplatin—bone cancer	0.000242	0.00121	CcSEcCtD
Tiagabine—Weight increased—Epirubicin—bone cancer	0.000242	0.0012	CcSEcCtD
Tiagabine—Haematuria—Methotrexate—bone cancer	0.000241	0.0012	CcSEcCtD
Tiagabine—Weight decreased—Epirubicin—bone cancer	0.00024	0.0012	CcSEcCtD
Tiagabine—Hyperglycaemia—Epirubicin—bone cancer	0.000239	0.00119	CcSEcCtD
Tiagabine—Angina pectoris—Doxorubicin—bone cancer	0.000239	0.00119	CcSEcCtD
Tiagabine—Epistaxis—Methotrexate—bone cancer	0.000239	0.00119	CcSEcCtD
Tiagabine—Pneumonia—Epirubicin—bone cancer	0.000238	0.00119	CcSEcCtD
Tiagabine—Bronchitis—Doxorubicin—bone cancer	0.000236	0.00118	CcSEcCtD
Tiagabine—Renal failure—Epirubicin—bone cancer	0.000233	0.00116	CcSEcCtD
Tiagabine—Body temperature increased—Cisplatin—bone cancer	0.000232	0.00116	CcSEcCtD
Tiagabine—Neuropathy peripheral—Epirubicin—bone cancer	0.000232	0.00116	CcSEcCtD
Tiagabine—Stomatitis—Epirubicin—bone cancer	0.000231	0.00115	CcSEcCtD
Tiagabine—Urinary tract infection—Epirubicin—bone cancer	0.00023	0.00115	CcSEcCtD
Tiagabine—Conjunctivitis—Epirubicin—bone cancer	0.00023	0.00115	CcSEcCtD
Tiagabine—Dysuria—Doxorubicin—bone cancer	0.00023	0.00115	CcSEcCtD
Tiagabine—Haemoglobin—Methotrexate—bone cancer	0.000228	0.00114	CcSEcCtD
Tiagabine—Haemorrhage—Methotrexate—bone cancer	0.000227	0.00113	CcSEcCtD
Tiagabine—Sweating—Epirubicin—bone cancer	0.000227	0.00113	CcSEcCtD
Tiagabine—Pollakiuria—Doxorubicin—bone cancer	0.000227	0.00113	CcSEcCtD
Tiagabine—Haematuria—Epirubicin—bone cancer	0.000226	0.00113	CcSEcCtD
Tiagabine—Pharyngitis—Methotrexate—bone cancer	0.000225	0.00112	CcSEcCtD
Tiagabine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000224	0.00112	CcSEcCtD
Tiagabine—Weight increased—Doxorubicin—bone cancer	0.000224	0.00111	CcSEcCtD
Tiagabine—Epistaxis—Epirubicin—bone cancer	0.000223	0.00111	CcSEcCtD
Tiagabine—Weight decreased—Doxorubicin—bone cancer	0.000222	0.00111	CcSEcCtD
Tiagabine—Sinusitis—Epirubicin—bone cancer	0.000222	0.00111	CcSEcCtD
Tiagabine—Hyperglycaemia—Doxorubicin—bone cancer	0.000222	0.00111	CcSEcCtD
Tiagabine—Pneumonia—Doxorubicin—bone cancer	0.00022	0.0011	CcSEcCtD
Tiagabine—Visual impairment—Methotrexate—bone cancer	0.000219	0.00109	CcSEcCtD
Tiagabine—Hypersensitivity—Cisplatin—bone cancer	0.000217	0.00108	CcSEcCtD
Tiagabine—Renal failure—Doxorubicin—bone cancer	0.000215	0.00107	CcSEcCtD
Tiagabine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000215	0.00107	CcSEcCtD
Tiagabine—Haemoglobin—Epirubicin—bone cancer	0.000214	0.00107	CcSEcCtD
Tiagabine—Stomatitis—Doxorubicin—bone cancer	0.000213	0.00106	CcSEcCtD
Tiagabine—Rhinitis—Epirubicin—bone cancer	0.000213	0.00106	CcSEcCtD
Tiagabine—Urinary tract infection—Doxorubicin—bone cancer	0.000213	0.00106	CcSEcCtD
Tiagabine—Conjunctivitis—Doxorubicin—bone cancer	0.000213	0.00106	CcSEcCtD
Tiagabine—Haemorrhage—Epirubicin—bone cancer	0.000212	0.00106	CcSEcCtD
Tiagabine—Tinnitus—Methotrexate—bone cancer	0.000212	0.00106	CcSEcCtD
Tiagabine—Hypoaesthesia—Epirubicin—bone cancer	0.000211	0.00105	CcSEcCtD
Tiagabine—Asthenia—Cisplatin—bone cancer	0.000211	0.00105	CcSEcCtD
Tiagabine—Pharyngitis—Epirubicin—bone cancer	0.000211	0.00105	CcSEcCtD
Tiagabine—Sweating—Doxorubicin—bone cancer	0.00021	0.00105	CcSEcCtD
Tiagabine—Oedema peripheral—Epirubicin—bone cancer	0.000209	0.00104	CcSEcCtD
Tiagabine—Haematuria—Doxorubicin—bone cancer	0.000209	0.00104	CcSEcCtD
Tiagabine—Epistaxis—Doxorubicin—bone cancer	0.000207	0.00103	CcSEcCtD
Tiagabine—Sinusitis—Doxorubicin—bone cancer	0.000205	0.00102	CcSEcCtD
Tiagabine—Visual impairment—Epirubicin—bone cancer	0.000205	0.00102	CcSEcCtD
Tiagabine—Chills—Methotrexate—bone cancer	0.000204	0.00102	CcSEcCtD
Tiagabine—Diarrhoea—Cisplatin—bone cancer	0.000201	0.001	CcSEcCtD
Tiagabine—Alopecia—Methotrexate—bone cancer	0.000201	0.001	CcSEcCtD
Tiagabine—Tinnitus—Epirubicin—bone cancer	0.000198	0.000988	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—bone cancer	0.000198	0.000986	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—bone cancer	0.000197	0.000983	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—bone cancer	0.000197	0.000981	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—bone cancer	0.000196	0.000976	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—bone cancer	0.000195	0.000973	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—bone cancer	0.000194	0.000966	CcSEcCtD
Tiagabine—Dysgeusia—Methotrexate—bone cancer	0.000194	0.000965	CcSEcCtD
Tiagabine—Back pain—Methotrexate—bone cancer	0.000191	0.000954	CcSEcCtD
Tiagabine—Chills—Epirubicin—bone cancer	0.000191	0.000951	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—bone cancer	0.000189	0.000945	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—bone cancer	0.000188	0.000936	CcSEcCtD
Tiagabine—Vomiting—Cisplatin—bone cancer	0.000187	0.000932	CcSEcCtD
Tiagabine—Rash—Cisplatin—bone cancer	0.000185	0.000924	CcSEcCtD
Tiagabine—Dermatitis—Cisplatin—bone cancer	0.000185	0.000924	CcSEcCtD
Tiagabine—Ill-defined disorder—Methotrexate—bone cancer	0.000183	0.000915	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—bone cancer	0.000183	0.000914	CcSEcCtD
Tiagabine—Anaemia—Methotrexate—bone cancer	0.000183	0.000911	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—bone cancer	0.000182	0.000909	CcSEcCtD
Tiagabine—Tension—Epirubicin—bone cancer	0.000182	0.000905	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—bone cancer	0.000181	0.000903	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—bone cancer	0.00018	0.000896	CcSEcCtD
Tiagabine—Back pain—Epirubicin—bone cancer	0.000179	0.000892	CcSEcCtD
Tiagabine—Malaise—Methotrexate—bone cancer	0.000178	0.000889	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—bone cancer	0.000178	0.000887	CcSEcCtD
Tiagabine—Vertigo—Methotrexate—bone cancer	0.000178	0.000886	CcSEcCtD
Tiagabine—Leukopenia—Methotrexate—bone cancer	0.000177	0.000882	CcSEcCtD
Tiagabine—Chills—Doxorubicin—bone cancer	0.000176	0.00088	CcSEcCtD
Tiagabine—Nausea—Cisplatin—bone cancer	0.000175	0.000871	CcSEcCtD
Tiagabine—Alopecia—Doxorubicin—bone cancer	0.000174	0.000867	CcSEcCtD
Tiagabine—Cough—Methotrexate—bone cancer	0.000172	0.00086	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—bone cancer	0.000172	0.000856	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—bone cancer	0.000171	0.000853	CcSEcCtD
Tiagabine—Agitation—Epirubicin—bone cancer	0.00017	0.000848	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—bone cancer	0.000169	0.000841	CcSEcCtD
Tiagabine—Chest pain—Methotrexate—bone cancer	0.000168	0.000839	CcSEcCtD
Tiagabine—Arthralgia—Methotrexate—bone cancer	0.000168	0.000839	CcSEcCtD
Tiagabine—Myalgia—Methotrexate—bone cancer	0.000168	0.000839	CcSEcCtD
Tiagabine—Tension—Doxorubicin—bone cancer	0.000168	0.000838	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—bone cancer	0.000168	0.000836	CcSEcCtD
Tiagabine—Malaise—Epirubicin—bone cancer	0.000167	0.000832	CcSEcCtD
Tiagabine—Discomfort—Methotrexate—bone cancer	0.000166	0.000829	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—bone cancer	0.000166	0.000829	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—bone cancer	0.000166	0.000829	CcSEcCtD
Tiagabine—Syncope—Epirubicin—bone cancer	0.000166	0.000827	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—bone cancer	0.000166	0.000826	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—bone cancer	0.000166	0.000826	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—bone cancer	0.000165	0.000821	CcSEcCtD
Tiagabine—Palpitations—Epirubicin—bone cancer	0.000163	0.000815	CcSEcCtD
Tiagabine—Confusional state—Methotrexate—bone cancer	0.000163	0.000811	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—bone cancer	0.000163	0.000811	CcSEcCtD
Tiagabine—Cough—Epirubicin—bone cancer	0.000161	0.000805	CcSEcCtD
Tiagabine—Infection—Methotrexate—bone cancer	0.00016	0.000799	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—bone cancer	0.00016	0.000796	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—bone cancer	0.000159	0.000792	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—bone cancer	0.000158	0.000789	CcSEcCtD
Tiagabine—Thrombocytopenia—Methotrexate—bone cancer	0.000158	0.000788	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—bone cancer	0.000157	0.000785	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—bone cancer	0.000157	0.000785	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—bone cancer	0.000157	0.000785	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—bone cancer	0.000157	0.000784	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—bone cancer	0.000157	0.000783	CcSEcCtD
Tiagabine—Hyperhidrosis—Methotrexate—bone cancer	0.000156	0.000778	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—bone cancer	0.000156	0.000776	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—bone cancer	0.000154	0.00077	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—bone cancer	0.000154	0.000768	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—bone cancer	0.000154	0.000767	CcSEcCtD
Tiagabine—Anorexia—Methotrexate—bone cancer	0.000154	0.000767	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—bone cancer	0.000153	0.000765	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—bone cancer	0.000153	0.000764	CcSEcCtD
Tiagabine—Confusional state—Epirubicin—bone cancer	0.000152	0.000759	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—bone cancer	0.000151	0.000754	CcSEcCtD
Tiagabine—Oedema—Epirubicin—bone cancer	0.000151	0.000753	CcSEcCtD
Tiagabine—Hypotension—Methotrexate—bone cancer	0.000151	0.000752	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—bone cancer	0.00015	0.00075	CcSEcCtD
Tiagabine—Infection—Epirubicin—bone cancer	0.00015	0.000748	CcSEcCtD
Tiagabine—Cough—Doxorubicin—bone cancer	0.000149	0.000745	CcSEcCtD
Tiagabine—Shock—Epirubicin—bone cancer	0.000149	0.000741	CcSEcCtD
Tiagabine—Thrombocytopenia—Epirubicin—bone cancer	0.000148	0.000737	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—bone cancer	0.000148	0.000737	CcSEcCtD
Tiagabine—Tachycardia—Epirubicin—bone cancer	0.000147	0.000735	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000147	0.000733	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—bone cancer	0.000146	0.000728	CcSEcCtD
Tiagabine—Insomnia—Methotrexate—bone cancer	0.000146	0.000728	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—bone cancer	0.000146	0.000727	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—bone cancer	0.000146	0.000727	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—bone cancer	0.000146	0.000727	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—bone cancer	0.000145	0.000724	CcSEcCtD
Tiagabine—Paraesthesia—Methotrexate—bone cancer	0.000145	0.000722	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—bone cancer	0.000144	0.000718	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—bone cancer	0.000144	0.000718	CcSEcCtD
Tiagabine—Dyspnoea—Methotrexate—bone cancer	0.000144	0.000717	CcSEcCtD
Tiagabine—Somnolence—Methotrexate—bone cancer	0.000143	0.000715	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—bone cancer	0.000142	0.000711	CcSEcCtD
Tiagabine—Dyspepsia—Methotrexate—bone cancer	0.000142	0.000708	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—bone cancer	0.000141	0.000704	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—bone cancer	0.000141	0.000702	CcSEcCtD
Tiagabine—Decreased appetite—Methotrexate—bone cancer	0.00014	0.000699	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—bone cancer	0.00014	0.000697	CcSEcCtD
Tiagabine—Fatigue—Methotrexate—bone cancer	0.000139	0.000694	CcSEcCtD
Tiagabine—Infection—Doxorubicin—bone cancer	0.000139	0.000692	CcSEcCtD
Tiagabine—Pain—Methotrexate—bone cancer	0.000138	0.000688	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000138	0.000686	CcSEcCtD
Tiagabine—Shock—Doxorubicin—bone cancer	0.000137	0.000685	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—bone cancer	0.000137	0.000682	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—bone cancer	0.000137	0.000681	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—bone cancer	0.000136	0.00068	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—bone cancer	0.000136	0.000676	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—bone cancer	0.000135	0.000673	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—bone cancer	0.000135	0.000671	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—bone cancer	0.000134	0.000669	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—bone cancer	0.000133	0.000664	CcSEcCtD
Tiagabine—Feeling abnormal—Methotrexate—bone cancer	0.000133	0.000663	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—bone cancer	0.000133	0.000663	CcSEcCtD
Tiagabine—Gastrointestinal pain—Methotrexate—bone cancer	0.000132	0.000658	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—bone cancer	0.000131	0.000655	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—bone cancer	0.000131	0.000651	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—bone cancer	0.00013	0.000649	CcSEcCtD
Tiagabine—Pain—Epirubicin—bone cancer	0.000129	0.000644	CcSEcCtD
Tiagabine—Constipation—Epirubicin—bone cancer	0.000129	0.000644	CcSEcCtD
Tiagabine—Urticaria—Methotrexate—bone cancer	0.000128	0.000639	CcSEcCtD
Tiagabine—Body temperature increased—Methotrexate—bone cancer	0.000128	0.000636	CcSEcCtD
Tiagabine—Abdominal pain—Methotrexate—bone cancer	0.000128	0.000636	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000127	0.000635	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—bone cancer	0.000126	0.00063	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—bone cancer	0.000125	0.000626	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—bone cancer	0.000125	0.000621	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—bone cancer	0.000124	0.00062	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—bone cancer	0.000124	0.000619	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—bone cancer	0.000123	0.000616	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—bone cancer	0.000123	0.000613	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—bone cancer	0.000121	0.000606	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—bone cancer	0.00012	0.000601	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—bone cancer	0.00012	0.000598	CcSEcCtD
Tiagabine—Pain—Doxorubicin—bone cancer	0.000119	0.000596	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—bone cancer	0.000119	0.000596	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—bone cancer	0.000119	0.000595	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—bone cancer	0.000119	0.000595	CcSEcCtD
Tiagabine—Hypersensitivity—Methotrexate—bone cancer	0.000119	0.000593	CcSEcCtD
Tiagabine—Asthenia—Methotrexate—bone cancer	0.000116	0.000577	CcSEcCtD
Tiagabine—Feeling abnormal—Doxorubicin—bone cancer	0.000115	0.000574	CcSEcCtD
Tiagabine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000114	0.00057	CcSEcCtD
Tiagabine—Pruritus—Methotrexate—bone cancer	0.000114	0.000569	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—bone cancer	0.000111	0.000555	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—bone cancer	0.000111	0.000553	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—bone cancer	0.00011	0.000551	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—bone cancer	0.00011	0.000551	CcSEcCtD
Tiagabine—Diarrhoea—Methotrexate—bone cancer	0.00011	0.00055	CcSEcCtD
Tiagabine—Asthenia—Epirubicin—bone cancer	0.000108	0.00054	CcSEcCtD
Tiagabine—Pruritus—Epirubicin—bone cancer	0.000107	0.000533	CcSEcCtD
Tiagabine—Dizziness—Methotrexate—bone cancer	0.000107	0.000532	CcSEcCtD
Tiagabine—Diarrhoea—Epirubicin—bone cancer	0.000103	0.000515	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—bone cancer	0.000103	0.000513	CcSEcCtD
Tiagabine—Vomiting—Methotrexate—bone cancer	0.000103	0.000512	CcSEcCtD
Tiagabine—Rash—Methotrexate—bone cancer	0.000102	0.000507	CcSEcCtD
Tiagabine—Dermatitis—Methotrexate—bone cancer	0.000102	0.000507	CcSEcCtD
Tiagabine—Headache—Methotrexate—bone cancer	0.000101	0.000504	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—bone cancer	0.0001	0.0005	CcSEcCtD
Tiagabine—Dizziness—Epirubicin—bone cancer	9.98e-05	0.000498	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—bone cancer	9.88e-05	0.000493	CcSEcCtD
Tiagabine—Vomiting—Epirubicin—bone cancer	9.6e-05	0.000479	CcSEcCtD
Tiagabine—Nausea—Methotrexate—bone cancer	9.58e-05	0.000478	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—bone cancer	9.56e-05	0.000477	CcSEcCtD
Tiagabine—Rash—Epirubicin—bone cancer	9.52e-05	0.000475	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—bone cancer	9.51e-05	0.000474	CcSEcCtD
Tiagabine—Headache—Epirubicin—bone cancer	9.46e-05	0.000472	CcSEcCtD
Tiagabine—Dizziness—Doxorubicin—bone cancer	9.24e-05	0.000461	CcSEcCtD
Tiagabine—Nausea—Epirubicin—bone cancer	8.97e-05	0.000447	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—bone cancer	8.88e-05	0.000443	CcSEcCtD
Tiagabine—Rash—Doxorubicin—bone cancer	8.81e-05	0.000439	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—bone cancer	8.8e-05	0.000439	CcSEcCtD
Tiagabine—Headache—Doxorubicin—bone cancer	8.75e-05	0.000436	CcSEcCtD
Tiagabine—Nausea—Doxorubicin—bone cancer	8.3e-05	0.000414	CcSEcCtD
